Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report

BACKGROUND: A variety of immune-modulating drugs are becoming increasingly used for various cancers. Despite increasing indications and improved efficacy, they are often associated with a wide variety of immune mediated adverse events including colitis that may be refractory to conventional therapy....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastrointest Pharmacol Ther
Main Authors: Nassri, Ammar B, Muenyi, Valery, AlKhasawneh, Ahmad, Ribeiro, Bruno De Souza, Scolapio, James S, Malespin, Miguel, de Melo Jr, Silvio W
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6347649/
https://ncbi.nlm.nih.gov/pubmed/30697447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v10.i1.29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados